Factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study participants, from March 2016 to May 2017.

Correlations between DENV-specific serum neutralizing titers and serum avidity over time.

Andreas Puschnik (421934)
Louis Lau (421935)
Elizabeth A. Cromwell (219060)
Angel Balmaseda (109173)
Simona Zompi (176420)
Eva Harris (27355)

June 2013

Correlation between DENV3-specific NT50 and IgM avidity to DENV3 in the acute phase of...

Age group-specific anti-DENV IgG seroprevalence in Thailand by region.

Sompong Vongpunsawad (684928)
Duangnapa Intharasongkroh (4183993)
Thanunrat Thongmee (732724)
Yong Poovorawan (39511)

June 2017

The line graphs represent regional DENV seroprevalence (y-axis) relative to age groups (x-axis). ...

Unadjusted and adjusted odds ratios for anti-DENV IgG and anti-CHIKV IgG seropositivity among blood donors residing in Qatar but from different regions.

John M. Humphrey (1601860)
Enas S. Al-Absi (6281936)
Munia M. Hamdan (6281939)
Sara S. Okasha (6281942)
Diyna M. Al-Trmanini (6281945)
Hend G. El-Dous (6281948)
Soha R. Dargham (3613250)
John Schieffelin (3468986)
Laith J. Abu-Raddad (92066)
Gheyath K. Nasrallah (2182598)

January 2019

Unadjusted and adjusted odds ratios for anti-DENV IgG and anti-CHIKV IgG seropositivity among blood ...

Risk factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study participants, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Risk factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study parti...

Factors associated with the prevalence of anti-DENV IgM seropositivity among the study participants, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Factors associated with the prevalence of anti-DENV IgM seropositivity among the study participan...

Risk factors associated with the prevalence of anti-DENV IgM seropositivity among the study participants, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Risk factors associated with the prevalence of anti-DENV IgM seropositivity among the study parti...

Weighted prevalence of serum anti-DENV IgG antibodies according to household variables in individuals aged ≥2 years, Mayotte, 2006.

Daouda Sissoko (95574)
Khaled Ezzedine (95577)
Claude Giry (95576)
Amrat Moendandzé (5653330)
Tinne Lernout (359275)
Eric D'Ortenzio (103332)
François Pettinelli (247358)
Denis Malvy (47735)

February 2013

Weighted prevalence of serum anti-DENV IgG antibodies according to household variables in individ...

Month-wise distributions of antibodies against DENV infection, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Blue diamonds: study participants with only anti-DENV IgM positive cases; red squares: study part...

Adjusted odds ratios for occurrence of anti-DENV IgG antibodies according to demographic and environmental variables in individuals aged ≥15 years, Mayotte, 2006.

Daouda Sissoko (95574)
Khaled Ezzedine (95577)
Claude Giry (95576)
Amrat Moendandzé (5653330)
Tinne Lernout (359275)
Eric D'Ortenzio (103332)
François Pettinelli (247358)
Denis Malvy (47735)

February 2013

Adjusted odds ratios for occurrence of anti-DENV IgG antibodies according to demographic and envi...

Country-specific seroprevalence for anti-DENV IgG and anti-CHIKV IgG among subjects residing in Qatar but from different countries, from June 2013 to June 2016.

John M. Humphrey (1601860)
Enas S. Al-Absi (6281936)
Munia M. Hamdan (6281939)
Sara S. Okasha (6281942)
Diyna M. Al-Trmanini (6281945)
Hend G. El-Dous (6281948)
Soha R. Dargham (3613250)
John Schieffelin (3468986)
Laith J. Abu-Raddad (92066)
Gheyath K. Nasrallah (2182598)

January 2019

Country-specific seroprevalence for anti-DENV IgG and anti-CHIKV IgG among subjects residing in Qata...

Factors associated with anti-Ov16 IgG4 seropositivity among residents of onchocerciasis-endemic areas of Hodeidah and Al-Mahwit, Yemen (2017).

Mohammed A. K. Mahdy (348145)
Rashad Abdul-Ghani (3180903)
Thaker A. A. Abdulrahman (4911490)
Samira M. A. Al-Eryani (4911487)
Abdulsalam M. Al-Mekhlafi (361625)
Sami A. A. Alhaidari (4911493)
Ahmed A. Azazy (361628)

March 2018

Factors associated with anti-Ov16 IgG4 seropositivity among residents of onchocerciasis-en...

Factors associated with B.melitensis seropositivity among study participants between May and July 2017.

Mariam M. Mirambo (5447642)
Georgies F. Mgode (832048)
Zakaria O. Malima (5447636)
Matata John (5447645)
Elifuraha B. Mngumi (5447639)
Ginethon G. Mhamphi (711302)
Stephen E. Mshana (383465)

June 2018

Factors associated with B.melitensis seropositivity among study participants betwee...

Factors associated with B.abortus seropositivity among study participants between May and July 2017.

Mariam M. Mirambo (5447642)
Georgies F. Mgode (832048)
Zakaria O. Malima (5447636)
Matata John (5447645)
Elifuraha B. Mngumi (5447639)
Ginethon G. Mhamphi (711302)
Stephen E. Mshana (383465)

June 2018

Factors associated with B.abortus seropositivity among study participants between M...

Unadjusted odds ratios for occurrence of serum anti-DENV IgG antibodies according to demographic and environmental variables in individuals aged ≥15 years, Mayotte, 2006.

Daouda Sissoko (95574)
Khaled Ezzedine (95577)
Claude Giry (95576)
Amrat Moendandzé (5653330)
Tinne Lernout (359275)
Eric D'Ortenzio (103332)
François Pettinelli (247358)
Denis Malvy (47735)

February 2013

Unadjusted odds ratios for occurrence of serum anti-DENV IgG antibodies according to demographic ...

DENV-1 and DENV-2 neutralizing antibody prevalence by year and birth cohort.

Brett M. Forshey (249475)
Robert C. Reiner (2137912)
Sandra Olkowski (2137909)
Amy C. Morrison (108730)
Angelica Espinoza (2137915)
Kanya C. Long (2137906)
Stalin Vilcarromero (372094)
Wilma Casanova (2137918)
Helen J. Wearing (245189)
Eric S. Halsey (129244)
Tadeusz J. Kochel (137222)
Thomas W. Scott (102260)
Steven T. Stoddard (167457)

February 2016

Samples were collected from longitudinal cohort studies conducted in Iquitos between 1993 and 201...

Correlations between DENV-specific serum neutralizing titers and serum avidity over time.

Andreas Puschnik (421934)
Louis Lau (421935)
Elizabeth A. Cromwell (219060)
Angel Balmaseda (109173)
Simona Zompi (176420)
Eva Harris (27355)

June 2013

Correlation between DENV3-specific NT50 and IgM avidity to DENV3 in the acute phase of...

Age group-specific anti-DENV IgG seroprevalence in Thailand by region.

Sompong Vongpunsawad (684928)
Duangnapa Intharasongkroh (4183993)
Thanunrat Thongmee (732724)
Yong Poovorawan (39511)

June 2017

The line graphs represent regional DENV seroprevalence (y-axis) relative to age groups (x-axis). ...

Unadjusted and adjusted odds ratios for anti-DENV IgG and anti-CHIKV IgG seropositivity among blood donors residing in Qatar but from different regions.

John M. Humphrey (1601860)
Enas S. Al-Absi (6281936)
Munia M. Hamdan (6281939)
Sara S. Okasha (6281942)
Diyna M. Al-Trmanini (6281945)
Hend G. El-Dous (6281948)
Soha R. Dargham (3613250)
John Schieffelin (3468986)
Laith J. Abu-Raddad (92066)
Gheyath K. Nasrallah (2182598)

January 2019

Unadjusted and adjusted odds ratios for anti-DENV IgG and anti-CHIKV IgG seropositivity among blood ...

Risk factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study participants, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Risk factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study parti...

Factors associated with the prevalence of anti-DENV IgM seropositivity among the study participants, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Factors associated with the prevalence of anti-DENV IgM seropositivity among the study participan...

Risk factors associated with the prevalence of anti-DENV IgM seropositivity among the study participants, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Risk factors associated with the prevalence of anti-DENV IgM seropositivity among the study parti...

Weighted prevalence of serum anti-DENV IgG antibodies according to household variables in individuals aged ≥2 years, Mayotte, 2006.

Daouda Sissoko (95574)
Khaled Ezzedine (95577)
Claude Giry (95576)
Amrat Moendandzé (5653330)
Tinne Lernout (359275)
Eric D'Ortenzio (103332)
François Pettinelli (247358)
Denis Malvy (47735)

February 2013

Weighted prevalence of serum anti-DENV IgG antibodies according to household variables in individ...

Month-wise distributions of antibodies against DENV infection, from March 2016 to May 2017.

Getachew Ferede (5324327)
Moges Tiruneh (5324324)
Ebba Abate (309550)
Yitayih Wondimeneh (5324333)
Demekech Damtie (5324330)
Endalamaw Gadisa (131395)
Rawleigh Howe (456745)
Abraham Aseffa (108981)
Belay Tessema (3181893)

May 2018

Blue diamonds: study participants with only anti-DENV IgM positive cases; red squares: study part...

Adjusted odds ratios for occurrence of anti-DENV IgG antibodies according to demographic and environmental variables in individuals aged ≥15 years, Mayotte, 2006.

Daouda Sissoko (95574)
Khaled Ezzedine (95577)
Claude Giry (95576)
Amrat Moendandzé (5653330)
Tinne Lernout (359275)
Eric D'Ortenzio (103332)
François Pettinelli (247358)
Denis Malvy (47735)

February 2013

Adjusted odds ratios for occurrence of anti-DENV IgG antibodies according to demographic and envi...

Country-specific seroprevalence for anti-DENV IgG and anti-CHIKV IgG among subjects residing in Qatar but from different countries, from June 2013 to June 2016.

John M. Humphrey (1601860)
Enas S. Al-Absi (6281936)
Munia M. Hamdan (6281939)
Sara S. Okasha (6281942)
Diyna M. Al-Trmanini (6281945)
Hend G. El-Dous (6281948)
Soha R. Dargham (3613250)
John Schieffelin (3468986)
Laith J. Abu-Raddad (92066)
Gheyath K. Nasrallah (2182598)

January 2019

Country-specific seroprevalence for anti-DENV IgG and anti-CHIKV IgG among subjects residing in Qata...

Factors associated with anti-Ov16 IgG4 seropositivity among residents of onchocerciasis-endemic areas of Hodeidah and Al-Mahwit, Yemen (2017).

Mohammed A. K. Mahdy (348145)
Rashad Abdul-Ghani (3180903)
Thaker A. A. Abdulrahman (4911490)
Samira M. A. Al-Eryani (4911487)
Abdulsalam M. Al-Mekhlafi (361625)
Sami A. A. Alhaidari (4911493)
Ahmed A. Azazy (361628)

March 2018

Factors associated with anti-Ov16 IgG4 seropositivity among residents of onchocerciasis-en...

Factors associated with B.melitensis seropositivity among study participants between May and July 2017.

Mariam M. Mirambo (5447642)
Georgies F. Mgode (832048)
Zakaria O. Malima (5447636)
Matata John (5447645)
Elifuraha B. Mngumi (5447639)
Ginethon G. Mhamphi (711302)
Stephen E. Mshana (383465)

June 2018

Factors associated with B.melitensis seropositivity among study participants betwee...

Factors associated with B.abortus seropositivity among study participants between May and July 2017.

Mariam M. Mirambo (5447642)
Georgies F. Mgode (832048)
Zakaria O. Malima (5447636)
Matata John (5447645)
Elifuraha B. Mngumi (5447639)
Ginethon G. Mhamphi (711302)
Stephen E. Mshana (383465)

June 2018

Factors associated with B.abortus seropositivity among study participants between M...

Unadjusted odds ratios for occurrence of serum anti-DENV IgG antibodies according to demographic and environmental variables in individuals aged ≥15 years, Mayotte, 2006.

Daouda Sissoko (95574)
Khaled Ezzedine (95577)
Claude Giry (95576)
Amrat Moendandzé (5653330)
Tinne Lernout (359275)
Eric D'Ortenzio (103332)
François Pettinelli (247358)
Denis Malvy (47735)

February 2013

Unadjusted odds ratios for occurrence of serum anti-DENV IgG antibodies according to demographic ...

DENV-1 and DENV-2 neutralizing antibody prevalence by year and birth cohort.

Brett M. Forshey (249475)
Robert C. Reiner (2137912)
Sandra Olkowski (2137909)
Amy C. Morrison (108730)
Angelica Espinoza (2137915)
Kanya C. Long (2137906)
Stalin Vilcarromero (372094)
Wilma Casanova (2137918)
Helen J. Wearing (245189)
Eric S. Halsey (129244)
Tadeusz J. Kochel (137222)
Thomas W. Scott (102260)
Steven T. Stoddard (167457)

February 2016

Samples were collected from longitudinal cohort studies conducted in Iquitos between 1993 and 201...

Correlations between DENV-specific serum neutralizing titers and serum avidity over time.

Andreas Puschnik (421934)
Louis Lau (421935)
Elizabeth A. Cromwell (219060)
Angel Balmaseda (109173)
Simona Zompi (176420)
Eva Harris (27355)

June 2013

Correlation between DENV3-specific NT50 and IgM avidity to DENV3 in the acute phase of...

Age group-specific anti-DENV IgG seroprevalence in Thailand by region.

Sompong Vongpunsawad (684928)
Duangnapa Intharasongkroh (4183993)
Thanunrat Thongmee (732724)
Yong Poovorawan (39511)

June 2017

The line graphs represent regional DENV seroprevalence (y-axis) relative to age groups (x-axis). ...

Unadjusted and adjusted odds ratios for anti-DENV IgG and anti-CHIKV IgG seropositivity among blood donors residing in Qatar but from different regions.

John M. Humphrey (1601860)
Enas S. Al-Absi (6281936)
Munia M. Hamdan (6281939)
Sara S. Okasha (6281942)
Diyna M. Al-Trmanini (6281945)
Hend G. El-Dous (6281948)
Soha R. Dargham (3613250)
John Schieffelin (3468986)
Laith J. Abu-Raddad (92066)
Gheyath K. Nasrallah (2182598)

January 2019

Unadjusted and adjusted odds ratios for anti-DENV IgG and anti-CHIKV IgG seropositivity among blood ...

Factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study participants, from March 2016 to May 2017.

Abstract

Extracted data

Factors associated with the prevalence of anti-DENV IgM-/G+ serostatus among the study participants, from March 2016 to May 2017.

Abstract

Extracted data

Related items

Related items